GLP Watchdog

Direct Meds vs Mochi Health

Direct Meds has an open FDA warning letter dated September 9, 2025. Mochi Health has none. On compounded oral semaglutide, Mochi Health costs $1,296 less a year at standing rates: $141 a month against $249 a month at Direct Meds.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Direct Meds / Mochi Health

Featured pick (affiliate partner)

Direct Meds logo

Direct Meds

7.1/10

Mochi Health logo

Mochi Health

7.1/10

FDA warning letters
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$249/moCompounded oral semaglutide
$110/moFoundayo (orforglipron) pill
States
48 states and DC
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Direct Meds
Visit Mochi Health

Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Mochi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, Mochi Health 7.1). How we are paid

What the record shows

  1. 01

    Direct Meds has an open FDA warning letter dated September 9, 2025. Mochi Health has none.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On compounded oral semaglutide, Mochi Health costs $1,296 less a year at standing rates: $141 a month against $249 a month at Direct Meds.

  4. 04

    Only Direct Meds lists a price for compounded oral tirzepatide. Only Mochi Health lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    Mochi Health covers two states Direct Meds does not.

  6. 06

    Direct Meds holds you to a 90-day supply shipped at once, remaining months billed every 30 days; Mochi Health states you can cancel at any time.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Direct Meds

Mochi Health

Compounded semaglutide injection

$297/mo

$3,564 a year

$139/mo

plan terms unclear; not compared

Compounded tirzepatide injection

$399/mo

$4,788 a year

$169/mo

plan terms unclear; not compared

Compounded oral semaglutide

$249/mo

$2,988 a year

$141/moLower

$1,692 a year

Brand-name semaglutide pen
Not sold or not priced

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen
Not sold or not priced

$299/mo

medication only, membership extra; not compared

Compounded oral tirzepatide

$299/mo

$3,588 a year

Not sold or not priced
Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$110/mo

$1,320 a year

Price includes
Medication, clinician visits, shipping
Clinician visits, coaching
Billed separately
Not stated
Medication
Cancel any time
No
Yes, stated
Minimum term
90-day supply shipped at once, remaining months billed every 30 days
None on the monthly plan; 3, 6 and 12-month memberships are prepaid
Refunds
No refunds for medication already received; $35 disposal fee on returns
No refunds for partly used periods; medication is not refundable once sent to the pharmacy

Read off each seller’s own pages. Direct Meds: October 17, 2026. Mochi Health: October 31, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Direct Meds

7.1/10
Featured pick (affiliate partner)
  • Sells compounded oral tirzepatide, which Mochi Health does not price
  • Open FDA warning letter, September 9, 2025
  • Names no compounding pharmacy
  • Minimum commitment before you can cancel
Visit Direct Meds

The case for Mochi Health

7.1/10
  • No FDA warning letter on record
  • $1,296 a year less on compounded oral semaglutide
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Direct Meds does not price
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Price leaves out medication
Visit Mochi Health

Scores

Direct Meds 7.1 · Mochi Health 7.1 out of 10. Six weighted parts.

Value25%

4.2A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.5

Trust & Safety15%

4.5A
vs
B
8.5

Accessibility10%

9.7A
vs
B
10.0

Support10%

7.0A
vs
B
4.0

The score is the same formula for every seller. Payment does not enter it. Method

Direct Meds vs Mochi Health: questions

Direct Meds has an open FDA warning letter dated September 9, 2025. Mochi Health has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
Mochi Health, by $1,296 a year at standing rates. Direct Meds: $249 a month, about $2,988 a year. Mochi Health: $141 a month, about $1,692 a year.
Direct Meds has a minimum term (90-day supply shipped at once, remaining months billed every 30 days). Mochi Health states you can cancel at any time; refunds: no refunds for partly used periods; medication is not refundable once sent to the pharmacy.
Direct Meds is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Mochi Health pays us nothing. The scores are computed the same way for both and are shown as computed (Direct Meds 7.1, Mochi Health 7.1).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks